journal article·2016-04

Continuous Flow Deformability‐Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets

Emily S. Park, Chao Jin, Quan Guo, Richard R. Ang, Simon P. Duffy, Kerryn Matthews, Arun Azad, Hamidreza Abdi, Tilman Todenhöfer, Jenny Bazov, Kim N. Chi, Peter C. Black, Hongshen Ma

Small· Volume 12· Issue 14
Publisher page

Abstract

Circulating tumor cells (CTCs) offer tremendous potential for the detection and characterization of cancer. A key challenge for their isolation and subsequent analysis is the extreme rarity of these cells in circulation. Here, a novel label‐free method is described to enrich viable CTCs directly from whole blood based on their distinct deformability relative to hematological cells. This mechanism leverages the deformation of single cells through tapered micrometer scale constrictions using oscillatory flow in order to generate a ratcheting effect that produces distinct flow paths for CTCs, leukocytes, and erythrocytes. A label‐free separation of circulating tumor cells from whole blood is demonstrated, where target cells can be separated from background cells based on deformability despite their nearly identical size. In doping experiments, this microfluidic device is able to capture >90% of cancer cells from unprocessed whole blood to achieve 104‐fold enrichment of target cells relative to leukocytes. In patients with metastatic castration‐resistant prostate cancer, where CTCs are not significantly larger than leukocytes, CTCs can be captured based on deformability at 25× greater yield than with the conventional CellSearch system. Finally, the CTCs separated using this approach are collected in suspension and are available for downstream molecular characterization.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Bio-sensing Technologies · Cancer Cells and Metastasis · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical Engineering University of British Columbia 2054‐6250 Applied Science Lane Vancouver BC V6T 1Z4 Canada

BC Cancer Agency–Vancouver Cancer Centre 600 West 10th Avenue Vancouver BC V5Z 1L3 Canada

Vancouver Prostate Centre 2660 Oak Street Vancouver BC V6H 3Z6 Canada

Funding

Canadian Institutes of Health Research · Natural Science and Engineering Research Council of Canada · Prostate Cancer Canada · Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development

References (59)

Show source-provided references
1. 10.1158/1078-0432.CCR-08-087210.1158/1078-0432.CCR-08-0872 ↗
2. 10.1056/NEJMoa04076610.1056/NEJMoa040766 ↗
3. 10.1158/1078-0432.CCR-05-176910.1158/1078-0432.CCR-05-1769 ↗
4. 10.1200/JCO.2007.15.892310.1200/JCO.2007.15.8923 ↗
5. 10.1093/annonc/mdp01710.1093/annonc/mdp017 ↗
6. 10.1200/JCO.2009.24.681910.1200/JCO.2009.24.6819 ↗
7. 10.1158/0008-5472.CAN-08-366710.1158/0008-5472.CAN-08-3667 ↗
8. 10.1056/NEJMoa080066810.1056/NEJMoa0800668 ↗
9. 10.1038/nature0638510.1038/nature06385 ↗
10. 10.1126/scitranslmed.300561610.1126/scitranslmed.3005616 ↗
11. 10.1073/pnas.101253910710.1073/pnas.1012539107 ↗
12. 10.1158/1078-0432.CCR-04-037810.1158/1078-0432.CCR-04-0378 ↗
13. 10.1158/1078-0432.CCR-06-169510.1158/1078-0432.CCR-06-1695 ↗
14. Miller M. C. · J. Oncol. · 2010 · 617421
15. 10.1158/1078-0432.CCR-06-270110.1158/1078-0432.CCR-06-2701 ↗
16. 10.1016/j.canlet.2006.12.01410.1016/j.canlet.2006.12.014 ↗
17. 10.1158/1078-0432.CCR-05-063210.1158/1078-0432.CCR-05-0632 ↗
18. 10.1126/scitranslmed.300510910.1126/scitranslmed.3005109 ↗
19. 10.1186/1471-2407-12-17810.1186/1471-2407-12-178 ↗
20. 10.1136/jcp.13.5.41410.1136/jcp.13.5.414 ↗
21. 10.1038/nprot.2014.04410.1038/nprot.2014.044 ↗
22. 10.1038/srep0125910.1038/srep01259 ↗
23. 10.1016/j.bios.2012.07.02110.1016/j.bios.2012.07.021 ↗
24. 10.1039/C3LC50689D10.1039/C3LC50689D ↗
25. 10.1039/C5LC00078E10.1039/C5LC00078E ↗
26. 10.1021/ac301723s10.1021/ac301723s ↗
27. 10.1073/pnas.150448411210.1073/pnas.1504484112 ↗
28. 10.1063/1.477430410.1063/1.4774304 ↗
29. 10.1158/1078-0432.CCR-10-110510.1158/1078-0432.CCR-10-1105 ↗
30. 10.1371/journal.pone.006177010.1371/journal.pone.0061770 ↗
31. 10.1371/journal.pone.006714810.1371/journal.pone.0067148 ↗
32. 10.1371/journal.pone.008526410.1371/journal.pone.0085264 ↗
33. 10.1016/j.humpath.2006.08.02710.1016/j.humpath.2006.08.027 ↗
34. 10.1155/2010/86134110.1155/2010/861341 ↗
35. 10.1088/1478-3975/9/1/01600210.1088/1478-3975/9/1/016002 ↗
36. 10.1158/1078-0432.CCR-04-111010.1158/1078-0432.CCR-04-1110 ↗
37. 10.1006/bbrc.2000.236010.1006/bbrc.2000.2360 ↗
38. 10.1002/1097-0142(195905/06)12:3<590::AID-CNCR2820120318>3.0.CO;2-N10.1002/1097-0142(195905/06)12:3<590::AID-CNCR2820120318>3.0.CO;2-N ↗
39. Desitter I. · Anticancer Res. · 2011 · 31 · 427
40. 10.1016/S0002-9440(10)64706-210.1016/S0002-9440(10)64706-2 ↗
41. 10.1016/j.chroma.2007.05.06410.1016/j.chroma.2007.05.064 ↗
42. 10.1371/journal.pone.006746610.1371/journal.pone.0067466 ↗
43. 10.1039/c2lc20750h10.1039/c2lc20750h ↗
44. 10.1039/c2lc21045b10.1039/c2lc21045b ↗
45. 10.1063/1.481268810.1063/1.4812688 ↗
46. 10.1103/PhysRevE.83.05191010.1103/PhysRevE.83.051910 ↗
47. 10.1103/PhysRevE.80.04631910.1103/PhysRevE.80.046319 ↗
48. 10.1016/S0021-9290(99)00175-X10.1016/S0021-9290(99)00175-X ↗
49. 10.1039/c2lc40205j10.1039/c2lc40205j ↗
50. 10.1371/journal.pone.006177410.1371/journal.pone.0061774 ↗
51. 10.1002/cyto.b.2057310.1002/cyto.b.20573 ↗
52. 10.1002/cyto.a.2036910.1002/cyto.a.20369 ↗
53. 10.1038/sj.bjc.669077810.1038/sj.bjc.6690778 ↗
54. 10.1158/0008-5472.CAN-12-414010.1158/0008-5472.CAN-12-4140 ↗
55. 10.1371/journal.pone.003378810.1371/journal.pone.0033788 ↗
56. 10.1007/s10549-008-0290-010.1007/s10549-008-0290-0 ↗
57. 10.1158/0008-5472.CAN-04-433010.1158/0008-5472.CAN-04-4330 ↗
58. 10.1119/1.1090310.1119/1.10903 ↗
59. 10.1073/pnas.051019110310.1073/pnas.0510191103 ↗